The current ERAS market cap is 364.72M. The company's latest EPS is USD -0.4423 and P/E is -2.92.
Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 |
Operating Income | -109.25M | -124.88M | -247.45M | -141.53M |
Net Income | -101.66M | -122.76M | -242.81M | -125.04M |
Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 124.83M | 501.42M | 514.91M | 395.3M |
Total Liabilities | 17.4M | 44.89M | 103.06M | 78.61M |
Total Equity | -113.98M | 456.53M | 411.85M | 316.69M |
Market Cap | 364.72M |
Price to Earnings Ratio | -2.92 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 3.92 |
Price to Book Ratio | 1.15 |
Dividend Yield | - |
Shares Outstanding | 282.73M |
Average Volume (1 week) | 1.11M |
Average Volume (1 Month) | 1.29M |
52 Week Change | -46.69% |
52 Week High | 3.45 |
52 Week Low | 1.27 |
Spread (Intraday) | 0.1 (7.3%) |
Company Name | Erasca Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.erasca.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions